The m 6 A Reader YTHDF1 Promotes Lung Carcinoma Progression via Regulating Ferritin Mediate Ferroptosis in an m 6 A-Dependent Manner

N6-methyladenosine (m A) plays a significant role as an epigenetic mechanism, which is involved in various cancers' progress via regulating mRNA modification. As a crucial m A "reader", YTHDF1 is able to alter m A-modified mRNA and promote the protein translation process in multiple c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmaceuticals (Basel, Switzerland) Switzerland), 2023-01, Vol.16 (2)
Hauptverfasser: Diao, Hongtao, Tan, Huiling, Hu, Yaju, Wang, Ruonan, Cai, Pingdong, Huang, Bingying, Shao, Xiaoqi, Yan, Meiling, Yin, Chuntong, Zhang, Yue
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 2
container_start_page
container_title Pharmaceuticals (Basel, Switzerland)
container_volume 16
creator Diao, Hongtao
Tan, Huiling
Hu, Yaju
Wang, Ruonan
Cai, Pingdong
Huang, Bingying
Shao, Xiaoqi
Yan, Meiling
Yin, Chuntong
Zhang, Yue
description N6-methyladenosine (m A) plays a significant role as an epigenetic mechanism, which is involved in various cancers' progress via regulating mRNA modification. As a crucial m A "reader", YTHDF1 is able to alter m A-modified mRNA and promote the protein translation process in multiple cancers. However, the role of YTHDF1 in lung cancer has not been fully investigated. This study focuses on elucidating the function of YTHDF1 in the development of lung cancer and its underlying mechanism. We demonstrated that YTHDF1 was highly expressed in lung carcinoma progression; then, the loss of function experiments in lung cell lines confirmed that knockdown of YTHDF1 suppressed cell proliferation, migration and invasion and induced ferroptosis of lung cancer cells. Further functional assays showed that ferritin (FTH) was identified as the key target of YTHDF1 in lung cancer cells. Furthermore, the overexpression of ferritin in YTHDF1-depleted cells partially restored lung cancer cell suppression. Collectively, our data suggested that the upregulation of YTHDF1 promotes lung cancer carcinogenesis by accelerating ferritin translation in an m A-dependent manner. We hope that our findings may provide a new target for lung cancer diagnosis and treatment.
doi_str_mv 10.3390/ph16020185
format Article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_37259333</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>37259333</sourcerecordid><originalsourceid>FETCH-pubmed_primary_372593333</originalsourceid><addsrcrecordid>eNqFjs1Kw0AUhQdRbKtufAC5LxA7k0madimtoQsLItm4KldzTUc6P9yZCO59cFN_wJ2rc_g4h3OEuFTyWuuFnIadmslcqnl5JMaqyItsnhfV8R8_EpMYX6UsK1WoUzHSVV4utNZj8dHsCCzM4AYeCFtieGzWq1rBPXvrE0W4610HS-Rn47zFA--YYjTewZvBodX1e0xmCNXEbAYHG2oNJvoCPiQfTYQBo_teylYUyLXkEmzQOeJzcfKC-0gXP3omrurbZrnOQv9kqd0GNhb5fft7W_8b-ATLN1Lj</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The m 6 A Reader YTHDF1 Promotes Lung Carcinoma Progression via Regulating Ferritin Mediate Ferroptosis in an m 6 A-Dependent Manner</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>PubMed Central</source><creator>Diao, Hongtao ; Tan, Huiling ; Hu, Yaju ; Wang, Ruonan ; Cai, Pingdong ; Huang, Bingying ; Shao, Xiaoqi ; Yan, Meiling ; Yin, Chuntong ; Zhang, Yue</creator><creatorcontrib>Diao, Hongtao ; Tan, Huiling ; Hu, Yaju ; Wang, Ruonan ; Cai, Pingdong ; Huang, Bingying ; Shao, Xiaoqi ; Yan, Meiling ; Yin, Chuntong ; Zhang, Yue</creatorcontrib><description>N6-methyladenosine (m A) plays a significant role as an epigenetic mechanism, which is involved in various cancers' progress via regulating mRNA modification. As a crucial m A "reader", YTHDF1 is able to alter m A-modified mRNA and promote the protein translation process in multiple cancers. However, the role of YTHDF1 in lung cancer has not been fully investigated. This study focuses on elucidating the function of YTHDF1 in the development of lung cancer and its underlying mechanism. We demonstrated that YTHDF1 was highly expressed in lung carcinoma progression; then, the loss of function experiments in lung cell lines confirmed that knockdown of YTHDF1 suppressed cell proliferation, migration and invasion and induced ferroptosis of lung cancer cells. Further functional assays showed that ferritin (FTH) was identified as the key target of YTHDF1 in lung cancer cells. Furthermore, the overexpression of ferritin in YTHDF1-depleted cells partially restored lung cancer cell suppression. Collectively, our data suggested that the upregulation of YTHDF1 promotes lung cancer carcinogenesis by accelerating ferritin translation in an m A-dependent manner. We hope that our findings may provide a new target for lung cancer diagnosis and treatment.</description><identifier>ISSN: 1424-8247</identifier><identifier>EISSN: 1424-8247</identifier><identifier>DOI: 10.3390/ph16020185</identifier><identifier>PMID: 37259333</identifier><language>eng</language><publisher>Switzerland</publisher><ispartof>Pharmaceuticals (Basel, Switzerland), 2023-01, Vol.16 (2)</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,864,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37259333$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Diao, Hongtao</creatorcontrib><creatorcontrib>Tan, Huiling</creatorcontrib><creatorcontrib>Hu, Yaju</creatorcontrib><creatorcontrib>Wang, Ruonan</creatorcontrib><creatorcontrib>Cai, Pingdong</creatorcontrib><creatorcontrib>Huang, Bingying</creatorcontrib><creatorcontrib>Shao, Xiaoqi</creatorcontrib><creatorcontrib>Yan, Meiling</creatorcontrib><creatorcontrib>Yin, Chuntong</creatorcontrib><creatorcontrib>Zhang, Yue</creatorcontrib><title>The m 6 A Reader YTHDF1 Promotes Lung Carcinoma Progression via Regulating Ferritin Mediate Ferroptosis in an m 6 A-Dependent Manner</title><title>Pharmaceuticals (Basel, Switzerland)</title><addtitle>Pharmaceuticals (Basel)</addtitle><description>N6-methyladenosine (m A) plays a significant role as an epigenetic mechanism, which is involved in various cancers' progress via regulating mRNA modification. As a crucial m A "reader", YTHDF1 is able to alter m A-modified mRNA and promote the protein translation process in multiple cancers. However, the role of YTHDF1 in lung cancer has not been fully investigated. This study focuses on elucidating the function of YTHDF1 in the development of lung cancer and its underlying mechanism. We demonstrated that YTHDF1 was highly expressed in lung carcinoma progression; then, the loss of function experiments in lung cell lines confirmed that knockdown of YTHDF1 suppressed cell proliferation, migration and invasion and induced ferroptosis of lung cancer cells. Further functional assays showed that ferritin (FTH) was identified as the key target of YTHDF1 in lung cancer cells. Furthermore, the overexpression of ferritin in YTHDF1-depleted cells partially restored lung cancer cell suppression. Collectively, our data suggested that the upregulation of YTHDF1 promotes lung cancer carcinogenesis by accelerating ferritin translation in an m A-dependent manner. We hope that our findings may provide a new target for lung cancer diagnosis and treatment.</description><issn>1424-8247</issn><issn>1424-8247</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNqFjs1Kw0AUhQdRbKtufAC5LxA7k0madimtoQsLItm4KldzTUc6P9yZCO59cFN_wJ2rc_g4h3OEuFTyWuuFnIadmslcqnl5JMaqyItsnhfV8R8_EpMYX6UsK1WoUzHSVV4utNZj8dHsCCzM4AYeCFtieGzWq1rBPXvrE0W4610HS-Rn47zFA--YYjTewZvBodX1e0xmCNXEbAYHG2oNJvoCPiQfTYQBo_teylYUyLXkEmzQOeJzcfKC-0gXP3omrurbZrnOQv9kqd0GNhb5fft7W_8b-ATLN1Lj</recordid><startdate>20230125</startdate><enddate>20230125</enddate><creator>Diao, Hongtao</creator><creator>Tan, Huiling</creator><creator>Hu, Yaju</creator><creator>Wang, Ruonan</creator><creator>Cai, Pingdong</creator><creator>Huang, Bingying</creator><creator>Shao, Xiaoqi</creator><creator>Yan, Meiling</creator><creator>Yin, Chuntong</creator><creator>Zhang, Yue</creator><scope>NPM</scope></search><sort><creationdate>20230125</creationdate><title>The m 6 A Reader YTHDF1 Promotes Lung Carcinoma Progression via Regulating Ferritin Mediate Ferroptosis in an m 6 A-Dependent Manner</title><author>Diao, Hongtao ; Tan, Huiling ; Hu, Yaju ; Wang, Ruonan ; Cai, Pingdong ; Huang, Bingying ; Shao, Xiaoqi ; Yan, Meiling ; Yin, Chuntong ; Zhang, Yue</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmed_primary_372593333</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Diao, Hongtao</creatorcontrib><creatorcontrib>Tan, Huiling</creatorcontrib><creatorcontrib>Hu, Yaju</creatorcontrib><creatorcontrib>Wang, Ruonan</creatorcontrib><creatorcontrib>Cai, Pingdong</creatorcontrib><creatorcontrib>Huang, Bingying</creatorcontrib><creatorcontrib>Shao, Xiaoqi</creatorcontrib><creatorcontrib>Yan, Meiling</creatorcontrib><creatorcontrib>Yin, Chuntong</creatorcontrib><creatorcontrib>Zhang, Yue</creatorcontrib><collection>PubMed</collection><jtitle>Pharmaceuticals (Basel, Switzerland)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Diao, Hongtao</au><au>Tan, Huiling</au><au>Hu, Yaju</au><au>Wang, Ruonan</au><au>Cai, Pingdong</au><au>Huang, Bingying</au><au>Shao, Xiaoqi</au><au>Yan, Meiling</au><au>Yin, Chuntong</au><au>Zhang, Yue</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The m 6 A Reader YTHDF1 Promotes Lung Carcinoma Progression via Regulating Ferritin Mediate Ferroptosis in an m 6 A-Dependent Manner</atitle><jtitle>Pharmaceuticals (Basel, Switzerland)</jtitle><addtitle>Pharmaceuticals (Basel)</addtitle><date>2023-01-25</date><risdate>2023</risdate><volume>16</volume><issue>2</issue><issn>1424-8247</issn><eissn>1424-8247</eissn><abstract>N6-methyladenosine (m A) plays a significant role as an epigenetic mechanism, which is involved in various cancers' progress via regulating mRNA modification. As a crucial m A "reader", YTHDF1 is able to alter m A-modified mRNA and promote the protein translation process in multiple cancers. However, the role of YTHDF1 in lung cancer has not been fully investigated. This study focuses on elucidating the function of YTHDF1 in the development of lung cancer and its underlying mechanism. We demonstrated that YTHDF1 was highly expressed in lung carcinoma progression; then, the loss of function experiments in lung cell lines confirmed that knockdown of YTHDF1 suppressed cell proliferation, migration and invasion and induced ferroptosis of lung cancer cells. Further functional assays showed that ferritin (FTH) was identified as the key target of YTHDF1 in lung cancer cells. Furthermore, the overexpression of ferritin in YTHDF1-depleted cells partially restored lung cancer cell suppression. Collectively, our data suggested that the upregulation of YTHDF1 promotes lung cancer carcinogenesis by accelerating ferritin translation in an m A-dependent manner. We hope that our findings may provide a new target for lung cancer diagnosis and treatment.</abstract><cop>Switzerland</cop><pmid>37259333</pmid><doi>10.3390/ph16020185</doi></addata></record>
fulltext fulltext
identifier ISSN: 1424-8247
ispartof Pharmaceuticals (Basel, Switzerland), 2023-01, Vol.16 (2)
issn 1424-8247
1424-8247
language eng
recordid cdi_pubmed_primary_37259333
source DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; MDPI - Multidisciplinary Digital Publishing Institute; PubMed Central
title The m 6 A Reader YTHDF1 Promotes Lung Carcinoma Progression via Regulating Ferritin Mediate Ferroptosis in an m 6 A-Dependent Manner
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T04%3A37%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20m%206%20A%20Reader%20YTHDF1%20Promotes%20Lung%20Carcinoma%20Progression%20via%20Regulating%20Ferritin%20Mediate%20Ferroptosis%20in%20an%20m%206%20A-Dependent%20Manner&rft.jtitle=Pharmaceuticals%20(Basel,%20Switzerland)&rft.au=Diao,%20Hongtao&rft.date=2023-01-25&rft.volume=16&rft.issue=2&rft.issn=1424-8247&rft.eissn=1424-8247&rft_id=info:doi/10.3390/ph16020185&rft_dat=%3Cpubmed%3E37259333%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/37259333&rfr_iscdi=true